SEC Form 4 · accession 0001127602-16-043518
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 24, 2016
Accepted (ET)
Feb 26, 2016 · 12:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 24, 2016 | S | 600 | $71.65 | D | 390,234 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.655 | D | 390,134 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.68 | D | 390,034 | D | |
| Common Stock | Feb 24, 2016 | S | 200 | $71.69 | D | 389,834 | D | |
| Common Stock | Feb 24, 2016 | S | 90 | $71.705 | D | 389,744 | D | |
| Common Stock | Feb 24, 2016 | S | 10 | $71.71 | D | 389,734 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.72 | D | 389,634 | D | |
| Common Stock | Feb 24, 2016 | S | 200 | $71.73 | D | 389,434 | D | |
| Common Stock | Feb 24, 2016 | S | 200 | $71.735 | D | 389,234 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.755 | D | 389,134 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.76 | D | 389,034 | D | |
| Common Stock | Feb 24, 2016 | S | 400 | $71.78 | D | 388,634 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.785 | D | 388,534 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.79 | D | 388,434 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.80 | D | 388,334 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.81 | D | 388,234 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.815 | D | 388,134 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.825 | D | 388,034 | D | |
| Common Stock | Feb 24, 2016 | S | 200 | $71.83 | D | 387,834 | D | |
| Common Stock | Feb 24, 2016 | S | 200 | $71.84 | D | 387,634 | D | |
| Common Stock | Feb 24, 2016 | S | 200 | $71.86 | D | 387,434 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.885 | D | 387,334 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.90 | D | 387,234 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.91 | D | 387,134 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $71.92 | D | 387,034 | D | |
| Common Stock | Feb 24, 2016 | S | 200 | $71.93 | D | 386,834 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.